Article
Genetically supported drug target prioritization for rare diseases.
Genome medicine - 11 Jun 2026
Chen Robert, Duffy Áine, Mort Matthew, Cooper David N, Rocheleau Ghislain, Jordan Daniel M, Do Ron
Abstract excerpt
RareGPS is a machine-learning framework prioritizing drug targets for rare and uncommon diseases, integrating 11 genetic, clinical, and experimental evidence sources. It uses the full distribution of genetic associations across allele-frequency bins in an allelic-series model. Across 161 phenotypes, RareGPS outperforms existing resources for predicting drug indications and clinical trial progression; top 1%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
